CoChat

Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy

Open access

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Abstract

In chronic lymphocytic leukemia (CLL), acquired T-cell dysfunction impedes development of effective immunotherapeutic strategies, through as-yet unresolved mechanisms. We have previously shown that CD8+ T cells in CLL exhibit impaired activation and reduced glucose uptake after stimulation. CD8+ T cells in CLL patients are chronically exposed to leukemic B cells, which potentially impacts metabolic homeostasis resulting in aberrant metabolic reprogramming upon stimulation. Here, we report that resting CD8+ T cells in CLL have reduced intracellular glucose transporter 1 (GLUT1) reserves, and have an altered mitochondrial metabolic profile as displayed by increased mitochondrial respiration, membrane potential, and levels of reactive oxygen species. This coincided with decreased levels of peroxisome proliferator-activated receptor γ coactivator 1-α, and in line with that, CLL-derived CD8+ T cells showed impaired mitochondrial biogenesis upon stimulation. In search of a therapeutic correlate of these findings, we analyzed mitochondrial biogenesis in CD19-directed chimeric antigen receptor (CAR) CD8+ T cells prior to infusion in CLL patients (who were enrolled in NCT01747486 and NCT01029366 [https://clinicaltrials.gov]). Interestingly, in cases with a subsequent complete response, the infused CD8+ CAR T cells had increased mitochondrial mass compared with nonresponders, which positively correlated with the expansion and persistence of CAR T cells. Our findings demonstrate that GLUT1 reserves and mitochondrial fitness of CD8+ T cells are impaired in CLL. Therefore, boosting mitochondrial biogenesis in CAR T cells might improve the efficacy of CAR T-cell therapy and other emerging cellular immunotherapies.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood.2018885863

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 81 references

Cited by

See all 187

Metadata

Authors
van Bruggen, J. A. C., Martens, A. W. J., Fraietta, J. A., Hofland, T., Tonino, S. H., Eldering, E., Levin, M.-D., Siska, P. J., Endstra, S., Rathmell, J. C., June, C. H., Porter, D. L., Melenhorst, J. J., Kater, A. P., & van der Windt, G. J. W.
Affiliations
  • Department of Hematology, Cancer Center Amsterdam,
  • Amsterdam University Medical Centers (NL)
  • Abramson Cancer Center (US)
  • Cancer Center Amsterdam (NL)
  • Albert Schweitzer Ziekenhuis (NL)
  • University Hospital Regensburg (DE)
  • Vanderbilt University Medical Center (US)
  • Department of Pathology and Laboratory Medicine,
Corresponding author
Kater, Arnon P.
Venue
Blood
Published
2019-07-04
Volume
134
Issue
1
Pages
44-58
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2913094775
Cited by
187
References
81
Citations by year
2026: 17 · 2025: 26 · 2024: 25 · 2023: 29 · 2022: 33 · 2021: 24 · 2020: 27 · 2019: 6
FWCI
12.34
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
Funders
  • European Commission
  • ZonMw
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • National Institutes of Health
  • National Cancer Institute (RO1CA226983, R01CA226983, P01CA214278)
Topics
  • Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
Keywords
chronic lymphocytic leukemia, CD8+ T cells, mitochondrial fitness, mitochondrial biogenesis, glucose transporter 1, GLUT1, CAR T-cell therapy, CD19, T cell metabolic reprogramming, PPARγ coactivator-1α, reactive oxygen species, mitochondrial respiration, T cell dysfunction, complete response
MeSH terms
Receptors, Chimeric Antigen, Adult, Aged, Aged, 80 and over, Organelle Biogenesis, Female, Humans, Male, Middle Aged, Mitochondria, Leukemia, Lymphocytic, Chronic, B-Cell, Immunotherapy, Adoptive, CD8-Positive T-Lymphocytes, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy. https://app.cochat.ai/papers/10.1182/blood.2018885863
The paper
van Bruggen, J. A. C., Martens, A. W. J., Fraietta, J. A., Hofland, T., Tonino, S. H., Eldering, E., Levin, M.-D., Siska, P. J., Endstra, S., Rathmell, J. C., June, C. H., Porter, D. L., Melenhorst, J. J., Kater, A. P., & van der Windt, G. J. W. (2019). Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy. Blood. https://doi.org/10.1182/blood.2018885863

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.